HeatherFrazierMD

PubMed

• 16 citations
  Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial
  Chelsea Fechter, Heather Frazier, William B Marcus, Amina Farooq, Harinderjit Singh
  Ophthalmic Surgery, Lasers & Imaging Retina. 2016-11-01
• 2 citations
  Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy in a Predominantly Non-Asian Population: RIVAL Results.
  Amina Farooq, Heather Frazier, William B Marcus, Chelsea Fechter, Harinderjit Singh
  Ophthalmic Surgery, Lasers & Imaging Retina. 2017-01-01

Journal Articles

• Endolaserless Vitrectomy with Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASERLESS TRIAL)  
  Marcus D, Singh H, Starnes D, Walia H, Farooq A, Frazier H, Marcus W, Lalane R., Journal of Vitreoretinal Diseases. 2018; 2(3): 127-137
• Optical Coherence Tomography Angiographic, Visual Acuity and Anatomic Outcomes with Aflibercept for Diabetic Macular Edema after Bevacizumab and/or Ranibizumab  
  Marcus D, Frazier H, Taylor C, et al., J Clin Ophthalmol. 2019; 3(2): 185-193.
• Endolaserless Vitrectomy with Aflibercept for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASERLESS TRIAL): 1-Year Results  
  Marcus D, Starnes D, Walia H, Farooq A, Frazier H, Marcus W, Samy E, Lalane R, Singh H, Taylor C, J Clin Ophthalmol. 2020; 4(2): 254-265

Abstracts/Posters

• Complications, Compliance and 3-Year Outcomes after Endolaserless Vitrectomy with Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage
  Kasetty V, Starnes D, Frazier H, Singh H, Marcus D, Annual Meeting of the Association for Research in Vision and Ophthalmology, Virtual, 5/2021
• Complications, Compliance and 2-Year Outcomes after Endolaserless Vitrectomy with Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage
  Levy R, Starnes D, Walia H, Farooq A, Frazier H, Marcus W, Samy E, Taylor C, Lalane R, Singh H, Marcus D, Annual Meeting of the Association for Research in Vision and Ophthalmology, Virtual, 5/2020
• Intravitreal Aflibercept Injection for Persistent Diabetic Macular Edema after Treatment with Bevacizumab and/or Ranibizumab: ROTATED Trial 52 Week Results
  Taylor C, Frazier H, Rex P, Marcus W, Starnes D, Walia H, Singh H, Lalane R, Marcus D, Annual Meeting of the Association for Research in Vision and Ophthalmology, Vancouver, Canada, 5/2019
• Endolaserless Vitrectomy with Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage: LASERLESS TRIAL 1-Year Results
  Marcus D, Starnes D, Walia H, Farooq A, Frazier H, Marcus W, Samy E, Lalane R, Singh H, Annual Meeting of the Association for Research in Vision and Ophthalmology, Vancouver, Canada, 5/2019
• Intravitreal Aflibercept Injection for Persistent Diabetic Macular Edema after Treatment with Bevacizumab and/or Ranibizumab (ROTATED Trial): 6-Month ROTATED Trial Res...
  Marcus D, Frazier H, Rex P, Marcus W, Starnes D, Walia H, Taylor C, Singh H, Lalane R, Annual Meeting of the Association for Research in Vision and Ophthalmology, Honolulu, Hawaii, 5/2018
• Endolaserless Vitrectomy with Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASER LESS TRIAL): 44 Week Results
  Marcus D, Singh H, Farooq A, Starnes D, Walia H, Frazier H, Lalane R, Macula Society Meeting, Beverly Hills, California, 2/2018
• Endolaserless Vitrectomy with Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASERLESS TRIAL)
  Marcus D, Singh H, Farooq A, Starnes D, Walia H, Frazier H, American Society of Retinal Specialists, Boston, Massachusetts, 8/2017
• Endolaserless Vitrectomy with Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASERLESS Trial)
  Marcus D, Singh H, Farooq A, Starnes D, Walia H, Frazier H, Annual Meeting of the Association for Research in Vision and Ophthalmology, Baltimore, Maryland, 5/2017
• Ranibizumab (0.3 mg) for Persistent Diabetic Macular Edema after Recent, Frequent, and Chronic Bevacizumab (ROTATE Trial)
  Farooq A, Frazier H, Fechter C, Marcus W, Singh H, Marcus D, Annual Meeting of the Association for Research in Vision and Ophthalmology, Seattle, Washington, 5/2016
• Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy in a Predominantly Non-Asian Population (RIVAL Trial)
  Marcus D, Farooq A, Frazier H, Fechter C, Marcus W, Singh H, Annual Meeting of the Association for Research in Vision and Ophthalmology, Seattle, Washington, 5/2016
• Join now to see all